★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
editor@theamericanjournals.comPublisher Home ↗
Medical Sciences OPEN ACCESS

CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER

Hamza Abdukodirovich Rakhmanov
Assistant of department of pathological anatomy Samarkand State Medical Institute, Uzbekistan
Shavkat Erjigitovich Islamov
Doctor of Medical Sciences, associate professor at the department of pathological anatomy Samarkand State Medical Institute, Uzbekistan
Nodir Mukhammadievich Rahimov
Doctor of Medical Sciences, Assistant Professor, Department of Oncology Samarkand State Medical Institute, Uzbekistan
DOI Crossref DOI 10.37547/TAJMSPR/Volume04Issue02-05
tajmspr 2022
VOL. 4 / NO. 02 FEBRUARY
FULL TEXT PP. 17-22
DOWNLOAD PDF

View all articles in this issue ↗

VOLUME 4
ISSUE 02
YEAR 2022
PAGES 17-22
RESEARCH OVERVIEW

Abstract

The article highlights clinical and morphological characteristics of prostate cancer. The results of the carried out researches at the character study, pathogenesis of the development and diagnostics testify to the increase of number of so called "hormone-resistant" cases of the prostate cancer. It has been established that morphological diagnosis of prostate cancer is difficult, because signs of malignancy may be barely visible, which increases the probability of a false-negative result. At the same time there are many benign processes that mimic a malignant tumour, which can lead to misdiagnosis. In recent years, the use of immunohistological markers to detect basal layer cells has been recommended. Their level can be determined by immunohistochemical examination, which is elevated in prostate cancer. 

RESEARCH TOPICS

Keywords

Prostate cancer clinic morphology

Downloads

Download data is not yet available.
SOURCES & SCHOLARSHIP

References

  1. Bhojani N., Salomon L., Capitanio U., et al. External validation of the updated Partin tables in a cohort of French and Italian men.// Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol.73 - P.347-52.
  2. Derweesh I.H., Kupelian P.A. Continuing trends in pathological stage migration in radical prostatectomy specimens. //Urol. Oncol. – 2004. - Jul-Aug; 22(4): - P. 300-6.
  3. Eckersberger E., Finkelstein J., Sadri H., Margreiter M., Djavan B. et al Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. //Reviews in Urology. - Vol. 11 № 3. - 2009. – Р. 127-133
  4. Eble J.N. et al.: Pathology and Genetics: Tumors of the urinary system and male genital organs. WHO classification of tumors. World Health Organization, Geneva, - 2004. - 299 p.
  5. Epstein J.I., Netto G.J. Biopsy Interpretation of the Prostate. Philadelphia, JB Lippincott Williams & Wilkins, 2008. ISBN9781469887517- 440 p.
  6. Gretzer M.B., Partin A.W. PSA markers in prostate cancer detection. //Urol. Clin. North. Am. - 30, 2003. - 30 (4): - P. 677-86. doi: 10.1016/s0094-0143(03)00057-0.
  7. Islamov Sh.E. Subjectivity in defects in rendering medical aid // European science review, Vienna, 2018. - №11-12. – P. 95-97.
  8. Messing E.M., Manola J., Sarosdy M. et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer //N.Engl.J.Med. — 1999. — V. 341, № 9.— Р. 1781—1788.
  9. Prayer-Galetti T., Zattoni F., Capizzi A. et al. Disease free survival in patients with pathological C stage prostate cancer at radical reropubic prostatectomy submitted to adjuvant hormonal treatment //Eur.Urol. — 2000. — V. 38. — Аbstr. 504.
  10. Van de Kwast T. et al Single Prostatic Cancer Foci on Prostate Biopsy.// Eur Urol supp 7. 2008. – Р. 549-556.